N/A
Manufactured by DNA Labs, Inc.
1,258 FDA adverse event reports analyzed
Last updated: 2026-04-15
CANDIDA ALBICANS is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by DNA Labs, Inc.. The most commonly reported adverse reactions for CANDIDA ALBICANS include DIARRHOEA, FATIGUE, HEADACHE, PAIN, NAUSEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CANDIDA ALBICANS.
Out of 589 classified reports for CANDIDA ALBICANS:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 1,258 FDA FAERS reports that mention CANDIDA ALBICANS. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DIARRHOEA, FATIGUE, HEADACHE, PAIN, NAUSEA, ARTHRALGIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list DNA Labs, Inc. in connection with CANDIDA ALBICANS. Always verify the specific product and NDC with your pharmacist.